Bioventus Inc (BVS) — Strategic Asset Allocation Index
Bioventus Inc (BVS) has a Strategic Asset Allocation Index of 24.5% as of June 2023. Strategic assets (PP&E of $57.10 Million plus long-term investments of $-) total $57.10 Million, measured against net assets of $233.34 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Bioventus Inc Strategic Asset Allocation Index (2015–2022)
This chart shows how Bioventus Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2015 to 2022. As of June 2023, the index stands at 24.5%, representing strategic assets of $57.10 Million against net assets of $233.34 Million USD. Explore cash flow conversion of Bioventus Inc to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Bioventus Inc (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Bioventus Inc from 2015 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Bioventus Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.6% | $2.64 Million | $- | $2.64 Million | $412.22 Million | ▼ -9.2 pp |
| 2021 | 9.8% | $52.28 Million | $22.98 Million | $29.29 Million | $533.79 Million | ▼ -18.8 pp |
| 2020 | 28.6% | $41.22 Million | $21.84 Million | $19.38 Million | $144.16 Million | ▲ +12.8 pp |
| 2019 | 15.8% | $23.06 Million | $19.76 Million | $3.31 Million | $145.62 Million | ▲ +10.6 pp |
| 2018 | 5.2% | $7.54 Million | $4.76 Million | $2.78 Million | $145.27 Million | ▲ +0.2 pp |
| 2015 | 5.0% | $9.60 Million | $9.60 Million | $- | $192.34 Million | — |